Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
US8466130B2 · kind B2 · utility
1Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 4, 2009 |
| Grant date | Jun 18, 2013 |
| Priority date | — |
| Expiry date | May 15, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/572
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The inventions disclosed include methods of treating cancers and related neoplasias, especially prostate cancer, with pharmaceutically acceptable salts comprising lipophilic cation moieties linked to nitroxide or linked to hydroxylamine anti-oxidant groups.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.